Skip to content

Transdermal Testosterone for Poor Responder Patients Undergoing Controlled Ovarian Stimulation Prior to IVF

Transdermal Testosterone for Poor Responders Undergoing IVF

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03078569
Enrollment
30
Registered
2017-03-13
Start date
2017-03-31
Completion date
2018-07-31
Last updated
2017-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Female

Keywords

Poor responders

Brief summary

This study evaluates the efficacy of pre- IVF treatment with transdermal testosterone to enhance ovarian response in poor responders. a randomized controlled trial with two groups, treatment group with transdermal testosterone before IVF treatment and a control group with no treatment.

Detailed description

One of the major challenges of Assisted reproduction technology is treating women with low ovarian response,those women achieve very poor pregnancy rate with IVF. in recent years there is a focus

Interventions

DRUGTestosterone gel

treatment with testosterone gel

Sponsors

Wolfson Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 42 Years
Healthy volunteers
Yes

Inclusion criteria

* infertility patients undergoing ART regular menses normal function of thyroid, liver and kidney normal BMI (19.3-28.9) without use of any fertility drugs in the previous two months

Exclusion criteria

* patients with recurrent implantations failure (3 cycles and more) previous ovarian surgery uncontrolled medical illness severe endometriosis (stage 3-4) contraindication for testosterone use

Design outcomes

Primary

MeasureTime frameDescription
number of retrieved oocytes2 yearnumber of oocytes

Secondary

MeasureTime frameDescription
number of clinical pregnancies2.5 yearsnumber of pregnancies with fetal cardiac activity

Countries

Israel

Contacts

Primary Contactamir Mr shalev, MD
amirshalev75@yahoo.com97235028105
Backup Contactariel Mr weissman, Proffesor
ariel.weissman@gmail.com97235028106

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026